ENEAPHARM AT ESPGHAN 2025

🧬 Very proud to present our exceptional results at ESPGHAN 2025!

We’re excited to share our work on EN311, about pre-clinical résults in Helsinki.

🔍 What explores our poster:

👉 EN311 A novel formulation for enhanced enzyme delivery in EPI

👉 Robust preclinical data that demonstrates a strong therapeutic potential and confirm the promise for clinical success  of our candidate EN311

📍 Come meet Cloé Fabre and Jessica Tran at Poster #2800, 14-17 Mai 2025

🚀 Phase 2 is the next step — and it's coming soon.